You are on page 1of 5

Printed.

: 2023/12/29 10:46:55
CDL Courier

5990 Côte des Neiges, Montréal (Québec) Canada H3S 1Z5 Tel:(514) 344-8022 Fax:(514) 344-8024 E-Mail:service@laboratoirescdl.com

CHYSTSIAKOVA, HANNA CLIN. CURA MDCM -STE-CATHERINE


DANA ELBAZ M.D. (1009711)
4-1222 RUE BELANGER 4150 STE-CATHERINE OUEST, SUITE 403
Montreal (QC) MONTREAL (QC) H3Z 2Y5
H2S 1H8 CC.: Envoyez Copie: Patient (Par Courriel/Email) ()
Tel.: (438) 728-4098 /
Prelevement: CDL1 - Cdl Siege Social
RAMQ: CHYH77511819 Dossier:
Age: 46 Date of Birth: 1977/01/18 Gender: F

Lab ID: 20233620234 (STAT) Received: 2023/12/28 13:51:41 Completed: 2023/12/28 15:23:57
Patient Notes: 38499

Comments:
Blue Vacutainer Collected Time: 2023/12/28 13:53:00
Lavender Vacutainer Collected Time: 2023/12/28 13:53:00
Serum SST Vacutainer Collected Time: 2023/12/28 13:53:00
BIOCHEMISTRY
ANALYTE UNITS REFERENCE RESULT COMMENT
* Sodium mmol/L 136 - 145 140
* Potassium mmol/L 3.5 - 5.1 4.2
* Glycosylated Hemoglobin NGSP F of T 0.04 - 0.06 0.054
* Glycosylated Hemoglobin IFCC mmol/mole 20 - 42.1 36.0
* Creatinine umol/L 45 - 86 52

The use of a one of the cephalosporin antibiotics causes a falsely increased creatinine value.

EGFR (MDRD) mL/min/1.73 m2 60 - 120 > 60 > 60

The EGFR is based on the MDRD equation. The result is valid for adults >/= 18 years old. Values > 60
are considered normal unless the urine albumin creatinine ratio is > 2 mg/mmol. Decreasing values
between 15 & 60 indicate increasing severity of chronic kidney disease. Values < 15 are indicative of
kidney failure. The EGFR is not reliable for rapidly changing creatinine values, extremes in muscle
mass, body size or altered diet patterns. Cystatin C is suggested in these situations.

EGFR:African American (MDRD) mL/min/1.73 m2 60 - 120 > 60 > 60


* Albumin g/L 35 - 52 48
* Total Bilirubin umol/L 2 - 15 4
* ALT U/L 5 - 33 34 34
* Alkaline Phosphatase U/L 35 - 104 66

FINAL REPORT
Approved by: ANDREW WEIGENSBERG Ph.D., F.C.A.C.B.
Legend: Abnormal Result Most Recent Result
Page 1 of 5
Andrew Weigensberg Ph.D., FCACB, Laboratory Director, Andrew Weigensberg Ph.D., FCACB, CSPQ, Dr. C. De Bellefeuille Hematologist
* Accreditation.: ISO 15189 accredited, for the specific tests or types of tests listed in the scope of accreditation approved by SCC.
Printed.: 2023/12/29 10:46:55
CDL Courier

5990 Côte des Neiges, Montréal (Québec) Canada H3S 1Z5 Tel:(514) 344-8022 Fax:(514) 344-8024 E-Mail:service@laboratoirescdl.com

CHYSTSIAKOVA, HANNA CLIN. CURA MDCM -STE-CATHERINE


DANA ELBAZ M.D. (1009711)
4-1222 RUE BELANGER 4150 STE-CATHERINE OUEST, SUITE 403
Montreal (QC) MONTREAL (QC) H3Z 2Y5
H2S 1H8 CC.: Envoyez Copie: Patient (Par Courriel/Email) ()
Tel.: (438) 728-4098 /
Prelevement: CDL1 - Cdl Siege Social
RAMQ: CHYH77511819 Dossier:
Age: 46 Date of Birth: 1977/01/18 Gender: F

Lab ID: 20233620234 (STAT) Received: 2023/12/28 13:51:41 Completed: 2023/12/28 15:23:57

CARDIOVASCULAR RISK
ANALYTE UNITS REFERENCE RESULT COMMENT
* Cholesterol, Total mmol/L 3.15 - 5.18 4.42
* Triglycerides mmol/L 0.4 - 2.3 1.54

FOLLOWING THE RECOMMENDATIONS OF THE AMERICAN HEART ASSOCIATION.

OPTIMAL: <1.70
BORDERLINE HIGH: 1.70 - 2.25
HIGH: 2.26 - 5.64
VERY HIGH: > 5.64

* HDL Cholesterol mmol/L 1.05 - 1.55 2.48 2.48

FOLLOWING THE RECOMMENDATIONS OF THE NATIONAL CHOLESTEROL EDUCATION PROGRAM, ATP III CLASSIFICATION
LOW RISK: >=1.55
HIGH RISK: <=1.04

LDL Cholesterol mmol/L 1 - 3.36 1.23

FOLLOWING THE RECOMMENDATIONS OF THE AMERICAN HEART ASSOCIATION.

Desirable level : <2.59


Near or above desirable level: 2.59 - 3.36
Borderline High : 3.37 - 4.13
High : 4.14 - 4.91
Very High Risk : >/= 4.92

LDL Calculation not valid if triglyceride value greater than 4.50

FINAL REPORT
Approved by: ANDREW WEIGENSBERG Ph.D., F.C.A.C.B.
Legend: Abnormal Result Most Recent Result
Page 2 of 5
Andrew Weigensberg Ph.D., FCACB, Laboratory Director, Andrew Weigensberg Ph.D., FCACB, CSPQ, Dr. C. De Bellefeuille Hematologist
* Accreditation.: ISO 15189 accredited, for the specific tests or types of tests listed in the scope of accreditation approved by SCC.
Printed.: 2023/12/29 10:46:55
CDL Courier

5990 Côte des Neiges, Montréal (Québec) Canada H3S 1Z5 Tel:(514) 344-8022 Fax:(514) 344-8024 E-Mail:service@laboratoirescdl.com

CHYSTSIAKOVA, HANNA CLIN. CURA MDCM -STE-CATHERINE


DANA ELBAZ M.D. (1009711)
4-1222 RUE BELANGER 4150 STE-CATHERINE OUEST, SUITE 403
Montreal (QC) MONTREAL (QC) H3Z 2Y5
H2S 1H8 CC.: Envoyez Copie: Patient (Par Courriel/Email) ()
Tel.: (438) 728-4098 /
Prelevement: CDL1 - Cdl Siege Social
RAMQ: CHYH77511819 Dossier:
Age: 46 Date of Birth: 1977/01/18 Gender: F

Lab ID: 20233620234 (STAT) Received: 2023/12/28 13:51:41 Completed: 2023/12/28 15:23:57

CARDIOVASCULAR RISK
ANALYTE UNITS REFERENCE RESULT COMMENT

Non HDL mmol/L 0 - 3.37 1.94

Near Ideal: 3.37 - 4.12


Borderline: 4.13 - 4.8
High: 4.9 - 5.6
Very High: >/= 5.7
The stated reference interval is for individuals with 0 -1 risk factors for CHD(coronary heart
disease).If the individual has 2 or more risk factors the reference interval should be <2.6 mmol/L.

Total Cholesterol/HDL 0 - 4.4 1.8


LDL/HDL Ratio 0 - 2.9 0.5
SERUM INDICES
ANALYTE UNITS REFERENCE RESULT COMMENT
* Hemolysis Index 0-9 6
* Icteric Index 0-2 1
* Lipemia Index 0 - 22 54 54

The following tests can be adversely affected by lipemia:

Increase: Albumin (index >200)


Total Bilirubin (index >60)
UIBC (index >100)
Uric Acid (index >750)

Decrease: Lipase (index >150)

FINAL REPORT
Approved by: ANDREW WEIGENSBERG Ph.D., F.C.A.C.B.
Legend: Abnormal Result Most Recent Result
Page 3 of 5
Andrew Weigensberg Ph.D., FCACB, Laboratory Director, Andrew Weigensberg Ph.D., FCACB, CSPQ, Dr. C. De Bellefeuille Hematologist
* Accreditation.: ISO 15189 accredited, for the specific tests or types of tests listed in the scope of accreditation approved by SCC.
Printed.: 2023/12/29 10:46:56
CDL Courier

5990 Côte des Neiges, Montréal (Québec) Canada H3S 1Z5 Tel:(514) 344-8022 Fax:(514) 344-8024 E-Mail:service@laboratoirescdl.com

CHYSTSIAKOVA, HANNA CLIN. CURA MDCM -STE-CATHERINE


DANA ELBAZ M.D. (1009711)
4-1222 RUE BELANGER 4150 STE-CATHERINE OUEST, SUITE 403
Montreal (QC) MONTREAL (QC) H3Z 2Y5
H2S 1H8 CC.: Envoyez Copie: Patient (Par Courriel/Email) ()
Tel.: (438) 728-4098 /
Prelevement: CDL1 - Cdl Siege Social
RAMQ: CHYH77511819 Dossier:
Age: 46 Date of Birth: 1977/01/18 Gender: F

Lab ID: 20233620234 (STAT) Received: 2023/12/28 13:51:41 Completed: 2023/12/28 15:23:57

HEMATOLOGY
ANALYTE UNITS REFERENCE RESULT COMMENT
* Red Blood Cells 10e12/L 4.2 - 5.4 4.4
* Hemoglobin g/L 120 - 160 133
* Hematocrit F of T 0.370 - 0.470 0.409
* MCV fL 78 - 100 93
* MCH pg 27 - 34 30
* MCHC g/L 320 - 360 325
* RDW-CV % 11.5 - 14.0 12.5
* White Blood Cells 10e9/L 4.0 - 10.5 6.0
* Neutrophils # 10e9/L 1.5 - 6.6 3.3
* Neutrophils % F of T 0.37 - 0.75 0.56
* Lymphocytes # 10e9/L 1.5 - 3.5 2.1
* Lymphocytes % F of T 0.20 - 0.75 0.35
* Lymphocytes/Neutrophils 0.25 - 0.99 0.64
* Monocytes # 10e9/L 0 - 1.0 0.4
* Monocytes % F of T 0.02 - 0.10 0.06
* Eosinophils # 10e9/L 0 - 0.7 0.1
* Eosinophils % F of T 0.01 - 0.11 0.01
* Basophils # 10e9/L 0 - 0.1 0.06
* Basophils % F of T 0.00 - 0.02 0.01
* Immature granulocytes # 10e9/L 0 - 0.03 0.01
* Immature granulocytes % F of T 0 - 0.004 0.002
* Platelets 10e9/L 150 - 450 247
* MPV fL 7.4 - 12.8 9.7
ANEMIA PROFILE
ANALYTE UNITS REFERENCE RESULT COMMENT
* Ferritin ug/L 13 - 150 42.9
* Vitamin B12 pmol/L 156 - 698 482
THYROID PROFILE
ANALYTE UNITS REFERENCE RESULT COMMENT
* Thyroid Stim. Hormone mIU/L 0.27 - 4.2 1.46

FINAL REPORT
Approved by: ANDREW WEIGENSBERG Ph.D., F.C.A.C.B.
Legend: Abnormal Result Most Recent Result
Page 4 of 5
Andrew Weigensberg Ph.D., FCACB, Laboratory Director, Andrew Weigensberg Ph.D., FCACB, CSPQ, Dr. C. De Bellefeuille Hematologist
* Accreditation.: ISO 15189 accredited, for the specific tests or types of tests listed in the scope of accreditation approved by SCC.
Printed.: 2023/12/29 10:46:56
CDL Courier

5990 Côte des Neiges, Montréal (Québec) Canada H3S 1Z5 Tel:(514) 344-8022 Fax:(514) 344-8024 E-Mail:service@laboratoirescdl.com

CHYSTSIAKOVA, HANNA CLIN. CURA MDCM -STE-CATHERINE


DANA ELBAZ M.D. (1009711)
4-1222 RUE BELANGER 4150 STE-CATHERINE OUEST, SUITE 403
Montreal (QC) MONTREAL (QC) H3Z 2Y5
H2S 1H8 CC.: Envoyez Copie: Patient (Par Courriel/Email) ()
Tel.: (438) 728-4098 /
Prelevement: CDL1 - Cdl Siege Social
RAMQ: CHYH77511819 Dossier:
Age: 46 Date of Birth: 1977/01/18 Gender: F

Lab ID: 20233620234 (STAT) Received: 2023/12/28 13:51:41 Completed: 2023/12/28 15:23:57

COAGULATION
ANALYTE UNITS REFERENCE RESULT COMMENT
* PT (Quick Time) sec. 10.3 - 13.2 10.7
* INR 0.9 - 1.1 0.88 0.88

INR THERAPEUTIC RANGES

TREATMENT AND PROPHYLAXIS OF VENOUS THROMBOSIS: 2.0 - 3.0


PATIENTS WITH MECHANICAL HEART VALVES: 2.5 - 3.5

* aPTT (TCA) sec. 26 - 36 33.7

FINAL REPORT
Approved by: ANDREW WEIGENSBERG Ph.D., F.C.A.C.B.
Legend: Abnormal Result Most Recent Result
Page 5 of 5
Andrew Weigensberg Ph.D., FCACB, Laboratory Director, Andrew Weigensberg Ph.D., FCACB, CSPQ, Dr. C. De Bellefeuille Hematologist
* Accreditation.: ISO 15189 accredited, for the specific tests or types of tests listed in the scope of accreditation approved by SCC.

You might also like